HA
Hathika Akbarali
About Hathika Akbarali
Data last updated:
Hathika Akbarali is a Director at Arkgen Pharma Private Limited (since 2016) and Additional Director at Arkgen Enterprises Private Limited (since 2016). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹17.85 Cr; the largest is Arkgen Pharma Private Limited at ₹16.92 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 May 2016 | 2014 | ₹16.92 Cr (FY 2025) | Active | |
| Additional Director | 19 May 2016 | 2005 | ₹92.7 Lakh (FY 2025) | Active |
Board colleagues of Hathika Akbarali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amal Amina Akberali Padiyath | 09326606 | Arkgen Pharma Private Limited | Director |
| Padiyath Mohammed Akbarali | 00372132 | Arkgen Pharma Private Limited , Arkgen Enterprises Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hathika Akbarali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hathika Akbarali
Hathika Akbarali currently holds 2 directorships: Arkgen Pharma Private Limited (Director, since 19 May 2016, revenue ₹16.92 Cr (FY 2025)); Arkgen Enterprises Private Limited (Additional Director, since 19 May 2016, revenue ₹92.7 Lakh (FY 2025)).
Hathika Akbarali was first appointed on 19 May 2016 as Director at Arkgen Pharma Private Limited.
The 2 current companies of Hathika Akbarali that report revenue have a combined latest revenue of ₹17.85 Cr: Arkgen Pharma Private Limited ₹16.92 Cr (FY 2025); Arkgen Enterprises Private Limited ₹92.7 Lakh (FY 2025).
The current boards of Hathika Akbarali's companies include Amal Amina Akberali Padiyath (Arkgen Pharma Private Limited), Padiyath Mohammed Akbarali (Arkgen Pharma Private Limited).